4[1]J.-P.Spanoa,P.Bussonb,D.Atlanc,et al.Nasopharyngeal carcinomas:An update.European Journal of Cancer,2003,39:2121
5[3]Eli Schwarz,Gordon KC Chiu,W Keung Leung.Oral health status of southern Chinese following head and neck irradiation therapy for nasopharyngeal carcinoma.Journal of Dentistry,1999,27:21
6[5]Sun D,Zhang Z,Van Do N,et al.Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker.Oral Oncology,2007,43(1):82
7[6]Edwin P Hui,Terence CW Poon,Peter ML Teo,et al.A prospective study of pre -treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.Radiotherapy and Oncology,2003,69:53
8[8]JC Li,CS Hu,GL Jiang,et al.Dose escalation of threedimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma:A Prospective Randomised Study.Clinical Oncology,2006,18:293
9[9]M Maalej,CN Ben Ammar,L Kochbati,et al.Brachytherapy for primary and recurrent nasopharyngeal carcinoma:Treatment techniques and results.Cancer Radiother,2007,2:1
10[10]McDermott AL,Dutt SN,Watkinson JC.The aetiology of nasopharyngeal carcinoma.Clin Otolaryngol,2001,26(2):82
